Novartis AG Drug for Smoker’s Cough Boosts Lung Function in Study

Novartis AG (NOVN)s experimental drug for smokers cough helped patients in a late-stage trial, and was at least as good as a treatment sold by Boehringer Ingelheim GmbH and Pfizer Inc. (PFE) In a tria…
Read the full story: BioSpace.com Featured News